Company profile
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. It offers A+Pre, a device that prepares blood samples for testing; the AC-1000, a device that separates cancer cells from the rest of the blood; A+SCDrop, a device that isolates individual cells; and A+CellScan, a device that stains and automatically counts cancer cells. The company provides
- CEO
- Mr. Xiaomin Chen Ph.D.
- Headquarters
- Tsuen Wan, Hong Kong
- Employees
- 12
- IPO date
- Mar 6, 2025
- Sector
- Healthcare
- Industry
- Diagnostics & Research